Drug-induced pigmentation
Around 10% to 20% of all cases of acquired hyperpigmentation are drug-induced. The underlying pathogenesis for drug-induced pigmentation includes melanin accumulation, drug accumulation, toxic effects on melanocytes, and hypersecretion of adrenocorticotropic hormone and melanocyte-stimulating hormon...
Main Authors: | Arunachalam Narayanan, Laxmisha Chandrashekhar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Pigment International |
Subjects: | |
Online Access: | http://www.pigmentinternational.com/article.asp?issn=2349-5847;year=2022;volume=9;issue=2;spage=82;epage=92;aulast=Narayanan |
Similar Items
-
Skin Pigmentation Types, Causes and Treatment—A Review
by: Amin Mahmood Thawabteh, et al.
Published: (2023-06-01) -
Shining Light on Autophagy in Skin Pigmentation and Pigmentary Disorders
by: Daniela Kovacs, et al.
Published: (2022-09-01) -
Melasma-like hyperpigmentation: A rare side effect of imatinib mesylate
by: Shreya Agrawal, et al.
Published: (2023-01-01) -
Familial Amyloidosis Cutis Dyschromica: a Case Report
by: Farideh Dehghani, et al.
Published: (2014-02-01) -
Laser-Assisted Depigmentation—An Introspection of the Science, Techniques, and Perceptions
by: Alex Mathews Muruppel, et al.
Published: (2020-08-01)